HealthStream (HSTM) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of HealthStream (NASDAQ:HSTM) from a hold rating to a sell rating in a report released on Wednesday morning.

According to Zacks, “HealthStream is dedicated to improving patient outcomes through the development of healthcare organizations’ greatest asset: their people. Their unified suite of solutions is contracted by, collectively, over 4.5 million healthcare employees in the U.S. for workforce development, training & learning management, talent management, performance assessment, and managing simulation-based education programs. Their research solutions provide valuable insight to healthcare providers to meet HCAHPS requirements, improve the patient experience, engage their workforce, and enhance physician alignment. Their provider solutions offer healthcare providers innovative tools to support healthcare organizations in appropriately credentialing and privileging their workforce. “

HSTM has been the topic of a number of other reports. Robert W. Baird cut their price objective on HealthStream from $30.00 to $28.00 and set an outperform rating on the stock in a report on Wednesday, October 25th. ValuEngine upgraded HealthStream from a sell rating to a hold rating in a report on Wednesday. Canaccord Genuity restated a hold rating and issued a $25.00 price objective on shares of HealthStream in a report on Monday, October 23rd. Finally, Needham & Company LLC downgraded HealthStream from a buy rating to a hold rating in a report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average price target of $24.83.

HealthStream (HSTM) traded up $0.37 during trading on Wednesday, hitting $23.62. The stock had a trading volume of 70,445 shares, compared to its average volume of 111,726. The stock has a market cap of $753.38, a P/E ratio of 131.23, a price-to-earnings-growth ratio of 4.99 and a beta of 0.91. HealthStream has a 52 week low of $20.60 and a 52 week high of $31.53.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings data on Monday, October 23rd. The technology company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. The company had revenue of $63.60 million for the quarter, compared to the consensus estimate of $62.48 million. HealthStream had a return on equity of 2.46% and a net margin of 2.36%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period last year, the business posted $0.04 EPS. research analysts forecast that HealthStream will post 0.23 earnings per share for the current fiscal year.

Several hedge funds have recently bought and sold shares of the company. FMR LLC grew its stake in shares of HealthStream by 2.5% in the second quarter. FMR LLC now owns 4,733,510 shares of the technology company’s stock valued at $124,586,000 after buying an additional 116,309 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of HealthStream by 4.0% in the second quarter. Vanguard Group Inc. now owns 2,324,958 shares of the technology company’s stock valued at $61,193,000 after buying an additional 89,220 shares in the last quarter. Conestoga Capital Advisors LLC grew its stake in shares of HealthStream by 14.3% in the third quarter. Conestoga Capital Advisors LLC now owns 1,497,650 shares of the technology company’s stock valued at $35,000,000 after buying an additional 186,948 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of HealthStream by 4.4% in the third quarter. Dimensional Fund Advisors LP now owns 1,239,449 shares of the technology company’s stock valued at $28,966,000 after buying an additional 51,900 shares in the last quarter. Finally, Janus Henderson Group PLC acquired a new stake in shares of HealthStream in the second quarter valued at about $23,186,000. Institutional investors and hedge funds own 74.32% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2018/01/07/healthstream-hstm-cut-to-sell-at-zacks-investment-research.html.

HealthStream Company Profile

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Get a free copy of the Zacks research report on HealthStream (HSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HealthStream (NASDAQ:HSTM)

What are top analysts saying about HealthStream? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthStream and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit